oncology
Medicines

Australia well positioned to respond to COVID vaccine-induced thrombotic thrombocytopenia

Australia has recorded its second case of vaccine-induced immune thrombotic thrombocytopenia (VITT) and clinicians will have a high index of suspicion for the new syndrome associated with the AstraZeneca COVID-19 vaccine. However the risk of VITT, also known as vaccine induced prothrombotic immune thrombocytopenia (VIPIT), remains extremely low and distinguishing it from other conditions has ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic